BIOA
BioAge Labs, Inc
NASDAQ: BIOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.85
-0.06% today
Updated 2026-04-30
Market cap
$756.98M
P/E ratio
—
P/S ratio
84.16x
EPS (TTM)
$-2.24
Dividend yield
—
52W range
$4 – $24
Volume
0.5M
BioAge Labs, Inc (BIOA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 7
Last 7 quarters
Avg EPS surprise
-10.6%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+28.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-1.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-3.2%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-19 | $-0.72 | -7.7% | $19.36 | $19.30 | -0.3% |
| 2025-11-06 | $-0.56 | -9.0% | $7.50 | $7.26 | -3.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.67 | $-0.72 | -7.7% | $3.08M | — |
| 2025-09-30 | $-0.51 | $-0.56 | -9.0% | $2.05M | — |
| 2025-06-30 | $-0.38 | $-0.60 | -57.3% | $2.41M | — |
| 2025-03-31 | $-0.53 | $-0.36 | +31.8% | $1.45M | — |
| 2024-12-31 | $-0.66 | $-1.00 | -52.7% | — | — |
| 2024-09-30 | $-0.73 | $-6.70 | -812.4% | — | — |
| 2024-06-30 | $0.00 | $-0.60 | — | — | — |
Frequently asked questions
Has BioAge Labs, Inc beaten earnings estimates?
BioAge Labs, Inc has beaten Wall Street EPS estimates in 1 of its last 7 quarterly reports, with an average EPS surprise of -10.6% over the last 4 quarters.
How does BIOA stock react to earnings?
BIOA stock has moved an average of -1.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.